Avian influenza and sialic acid receptors: More than meets the eye?

Lancet Infectious Diseases

Volumn 5, Issue 3, 2005, Pages 184-188

  Olofsson, Sigvard ^a   Kumlin, Urban ^b   Dimock, Ken ^c   Arnberg, Niklas ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; SIALIC ACID RECEPTOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR; CELL SURFACE RECEPTOR;

AVIADENOVIRUS; AVIAN INFLUENZA; CLINICAL FEATURE; EPIDEMIC; FLU LIKE SYNDROME; HEMORRHAGIC CONJUNCTIVITIS; HUMAN; KERATOCONJUNCTIVITIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; SEROTYPE; SIALYLATION; TARGET CELL; VIRUS ENVELOPE; VIRUS EXPRESSION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; ADENOVIRUS; ANIMAL; ARTICLE; BIRD; CLASSIFICATION; DISEASE TRANSMISSION; EYE DISEASE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SEROTYPING; VIROLOGY; ZOONOSIS;

ADENOVIRIDAE; ANIMALS; BIRDS; EYE DISEASES; HUMANS; INFLUENZA IN BIRDS; RECEPTORS, CELL SURFACE; SEROTYPING; ZOONOSES;

EID: 85047689738     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70026-8     Document Type: Review

References (76)

1. Stephenson I, Nicholson KG, Wood JM, Zambon MC, Katz JM. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect Dis. 4:2004;499-509
2. Ito T, Suzuki Y, Mitnaul L, Vines A, Kida H, Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology. 227:1997;493-499
3. Hinshaw VS, Webster RG, Naeve CW, Murphy BR. Altered tissue tropism of human-avian reassortant influenza viruses. Virology. 128:1983;260-263
4. Couceiro JN, Paulson JC, Baum LG. Influenza virus strains selectively recognise sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of haemagglutinin receptor specificity. Virus Res. 29:1993;155-165
5. Beare AS, Webster RG. Replication of avian influenza viruses in humans. Arch Virol. 119:1991;37-42
6. Fouchier RA, Schneeberger PM, Rozendaal FW, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA. 101:2004;1356-1361
7. Enserink M. Bird flu infected 1000, Dutch researchers say. Science. 306:2004;590
8. Bosman A, Mulder YM, Leeuw JR. et al. Avian flu epidemic 2003: public health consequences. Bilthoven, the Netherlands: Rijksinstituute voor Volksezondheid en Milieu: 2004; report 630940001. http://www.rivm.nl/ bibliotheek/rapporten/630940001.pdf (accessed Feb 4, 2005).
9. Webster RG, Geraci J, Petursson G, Skirnisson K. Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med. 304:1981;911
10. Webster RG, Hinshaw VS, Bean WJ, et al. Characterization of an influenza A virus from seals. Virology. 113:1981;712-724
11. Taylor HR, Turner AJ. A case report of fowl plague keratoconjunctivitis. Br J Ophthalmol. 61:1977;86-88
12. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet. 348:1996;901-902
13. Tweed SA, Skowronski DM, David TS, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Inf Dis. 10:2004;2196-2199
14. Tolchin S, Landrigan M. H7N2 avian influenza identified in Westchester resident. 2004. http://www.westchestergov.com/health/PressRelease_2004/ PR04202004(H7N2_Influenza_Case).pdf (accessed Feb 4, 2005).
15. Choi S, Tsang T. An update on influenza A H5N1 in Hong Kong. Public Health Epidemiol Bull. 7:1998;1-8
16. Tam JS. Influenza A (H5N1) in Hong Kong: an overview. Vaccine. 20:2002;77-81
17. Chan PKS. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 34:2002;58-64
18. Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 350:2004;1179-1188
19. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand 2004. Emerg Inf Dis. 11:2005;201-209
20. De Jong JC, Wigand R, Wadell G, et al. Adenovirus 37: identification and characterization of a medically important new adenovirus type of subgroup D. J Med Virol. 7:1981;105-118
21. Kemp MC, Hierholzer JC, Cabradilla CP, Obijeski JF. The changing etiology of epidemic keratoconjunctivitis: antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period. J Infect Dis. 148:1983;24-33
22. Aoki K, Kawana R, Matsumoto I, Wadell G, de Jong JC. Viral conjunctivitis with special reference to adenovirus type 37 and enterovirus 70 infection. Jpn J Ophthalmol. 30:1986;158-164
23. Gordon YJ, Aoki K, Kinchington PR. Adenovirus keratoconjunctivitis. Pepose JS, Holland GN, Wilhelmus KR. Ocular infection and immunity. 1996;877-894 Mosby, St Louis
24. Azar MJ, Dhaliwal DK, Bower KS, Kowalski RP, Gordon YJ. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol. 121:1996;711-712
25. Bradshaw CS, Denham IM, Fairley CK. Characteristics of adenovirus associated urethritis. Sex Transm Infect. 78:2002;445-447
26. Aoki K, Tagawa Y. A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Int Ophthalmol Clin. 42:2002;49-54
27. Arnberg N, Edlund K, Kidd AH, Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol. 74:2000;42-48
28. Burmeister WP, Guiligay DSC, Wadell G, Arnberg N. Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites. J Virol. 78:2004;7727-7736
29. Cashman SM, Morris DJ, Kumar-Singh R. Adenovirus type 5 pseudotyped with adenovirus type 37 fiber uses sialic acid as a cellular receptor. Virology. 324:2004;129-139
30. Higgins PG. Enteroviral conjunctivitis and its neurological complications. Arch Virol. 73:1982;91-101
31. Wright PW, Strauss GH, Langford MP. Acute hemorrhagic conjunctivitis. Am Fam Physician. 45:1992;173-178
32. Ishii K. Acute hemorrhagic conjunctivitis in the eastern hemisphere. Uchida Y, Ishii K, Miyamura K, Yamazaki S. Acute hemorrhagic conjunctivitis. Etiology, epidemiology, and clinical manifestations. 1989;11-33 S Karger AG, New York
33. Hierholzer JC, Pallansch MA. Acute hemorrhagic conjunctivitis in the western hemisphere (1980-1987). Uchida Y, Ishii K, Miyamura K, Yamazaki S. Acute hemorrhagic conjunctivitis. Etiology, epidemiology, and clinical manifestations. 1989;49-56 S Karger AG, New York
34. Wairagkar NS, Gogate SS, Labhsetwar AS. Investigation of an epidemic of acute haemorrhagic conjunctivitis in Pune, India. J Commun Dis. 31:1999;41-43
35. Maitreyi RS, Dar L, Muthukumar A, et al. Acute hemorrhagic conjunctivitis due to enterovirus 70 in India. Emerg Infect Dis. 5:1999;267-269
36. Uchio EK, Yamazaki K, Ishikawa H, et al. An epidemic of acute hemorrhagic conjunctivitis caused by enterovirus 70 in Okinawa, Japan, in 1994. Graefes Arch Clin Exp Ophthalmol. 237:1999;568-572
37. Shulman LM, Manor Y, Azar R, et al. Identification of a new strain of fastidious enterovirus 70 as the causative agent of an outbreak of hemorrhagic conjunctivitis. J Clin Microbiol. 35:1997;2145-2149
38. Yoshii T, Natori K, Kono R. Replication of enterovirus 70 in non-primate cell cultures. J Gen Virol. 36:1977;377-384
39. Karnauchow TM, Tolson DL, Harrison BA, et al. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol. 70:1996;5143-5152
40. Alexander DA, Dimock K. Sialic acid functions in enterovirus 70 binding and infection. J Virol. 76:2002;11265-11272
41. Nokhbeh MR, Hazra S, Alexander DA, et al. Enterovirus 70 binds to different glycoconjugates containing α2,3-linked sialic acid on different cell lines. J Virol (in press).
42. Haddad A, Nokhbeh MR, Alexander DA, et al. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70. J Virol. 78:2004;2674-2681
43. Spear PG. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol. 6:2004;401-410
44. Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature. 406:2000;893-897
45. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305
46. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med. 9:2003;1408-1412
47. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol. 77:2003;9183-9191
48. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk H-D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA. 101:2004;4620-4624
49. Baum LG, Paulson JC. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl. 40:1990;35-38
50. Gagneux P, Cheriyan M, Hurtado-Ziola N, et al. Human-specific regulation of alpha2-6 linked sialic acids. J Biol Chem. 278:2003;48245-48250
51. Terraciano AJ, Wang N, Schuman JS, et al. Sialyl Lewis X, Lewis X, and N-acetyllactosamine expression on normal and glaucomatous eyes. Curr Eye Res. 18:1999;73-78
52. Diebold Y, Calonge M, de Salamanca AE, et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 44:2003;4263-4274
53. Paulsen FP, Tschernig T, Debertin AS, et al. Similarities and differences in lectin cytochemistry of laryngeal and tracheal epithelium and subepithelial seromucous glands in cases of sudden infant death and controls. Thorax. 56:2001;223-227
54. Paulsen F, Thale A, Kohla G, et al. Functional anatomy of human lacrimal duct epithelium. Anat Embryol. 198:1998;1-12
55. Lamblin G, Degroote S, Perini JM, et al. Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J. 18:2001;661-684
56. Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res. 78:2004;379-388
57. Berry M, Ellingham RB, Corfield AP. Polydispersity of normal human conjunctival mucins. Invest Ophthalmol Vis Sci. 37:1996;2559-2571
58. Thale A, Paulsen F, Kohla G, et al. The efferent lacrimal ducts of the human. Morphological and biochemical studies. Ophthalmologe. 98:2001;67-73
59. Subbarao K, Webster RG, Kawaoka Y, Murphy BR. Are there alternative avian influenza viruses for generation of stable attenuated avian-human influenza A reassortant viruses? Virus Res. 39:1995;105-118
60. Snyder MH, London WT, Tierney EL, Maassab HF, Murphy BR. Restricted replication of a cold-adapted reassortant influenza A virus in the lower respiratory tract of chimpanzees. J Infect Dis. 154:1986;370-371
61. Scholtissek C, Naylor E. Fish farming and influenza pandemics. Nature. 331:1988;215
62. Matrosovich MN, Krauss S, Webster RG. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology. 281:2001;156-162
63. Li KS, Xu KM, Peiris JS, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol. 77:2003;6988-6994
64. Gambaryan A, Webster R, Matrosovich M. Differences between influenza virus receptors on target cells of duck and chicken. Arch Virol. 147:2002;1197-1208
65. Perez DR, Webby RJ, Hoffmann E, Webster RG. Land-based birds as potential disseminators of avian mammalian reassortant influenza A viruses. Avian Dis. 47:2003;1114-1147
66. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 363:2004;587-593
67. Rogers GN, Paulson JC, Daniels RS, et al. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature. 304:1983;76-78
68. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology. 278:2000;587-596
69. Harvey R, Martin AC, Zambon M, Barclay WS. Restrictions to the adaptation of influenza a virus H5 hemagglutinin to the human host. J Virol. 78:2004;502-507
70. Bell JA, Huebner RJ, Paffenbarger RSJW, et al. Studies of adenoviruses (APC) in volunteers. Am J Public Health. 46:1956;1130-1146
71. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med. 120:1996;140-155
72. McChesney MB, Miller CJ, Rota PA, et al. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology. 233:1997;74-84
73. Tannock GA, Paul JA, Barry RD. Immunization against influenza by the ocular route. Vaccine. 3:(suppl 3):1985;277-280
74. Nicholson KG. Human influenza. Nicholson KG, Webster RG, Hay AJ. Textbook of influenza. 1998;219-264 Blackwell Science, Oxford
75. Shortridge KF. Pandemic influenza: a zoonosis? Semin Respir Infect. 7:1992;11-25
76. Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 430:2004;209-213